Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy the ...
US appeals court appears skeptical of Meta, social media companies' bid to cut off addiction lawsuits A U.S. appeals court on Tuesday appeared inclined to allow lawsuits alleging major social media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback